Lauren Uzdienski

Research Associate

Ms. Uzdienski's primary responsibilities are to generate content for the HealthpointCapital blog and report pipeline, edit and market research products, manage content for HealthpointCapital's industry database and oversee the company's presence at conferences and industry events. She joins HealthpointCapital from the publishing industry.

B.A., New York University


Recent Articles by Lauren Uzdienski

Theken is Taken: Integra to Buy for up to $200 Million JUL 24, 2008

Integra LifeSciences this morning announced plans to acquire the Theken family of businesses - Theken Spine, Theken Disc and Therics - for $75.0 million (a 2.2x revenue multiple) plus up to $125.0 million in future performance-based payments. This acquisition represents... more

CMS Proposes National Non-Coverage Decision for IDET JUL 24, 2008

CMS proposed a national non-coverage decision for intradiscal electrothermic therapy (IDET), saying there is insufficient evidence that the procedure improves outcomes in the Medicare population. IDET is a minimally-invasive treatment for low back pain where a catheter and a heating... more

Zimmer Suspends Durom Sales, Cuts Guidance JUL 23, 2008

Zimmer's announced yesterday that they would voluntarily suspend sales of the Durom Acetabular Component in the U.S. while they update the labeling and conduct further surgeon training on the product. As a result, the company is lowering full-year revenue guidance... more

More Trouble for ArthroCare as Company Announces Plans to Restate Financials JUL 21, 2008

ArthroCare's stock was off almost 40% in midday training following an announcement this morning that the company would restate financials from 2006, 2007 and 1Q:08. The restatement stems from a number of issues, including how revenue from DiscoCare was classified,... more

Musculoskeletal News Roundup 17-July-08 JUL 17, 2008

Earnings Biomet reported FQ4:08 revenues of $635.6 million, an increase of 16% (10% constant currency) over the year-ago period. Sales increased 10% in the U.S and 24% (11% constant currency) OUS. Recon sales increased 17% worldwide (12% constant currency) to... more